[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340153-105":59,"doc-detail-340153-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mirnas-in-signal-transduction-of-smad-proteins-in-breast-cancer","miRNAs in Signal Transduction of SMAD Proteins in Breast Cancer","","The study identifies microRNAs (miRNAs) that may regulate SMAD protein activity within TGFβ signal transduction across five breast cancer subtypes in Polish women. Tumor tissue and control margins were analyzed using mRNA microarrays and RT-qPCR, with protein expression assessed by ELISA. miRNA profiling combined miRNA microarrays and the miRDB database. SMAD3 and SMAD5 were overexpressed in all subtypes, linked to reduced miR-145, while SMAD4 and miR-155 showed comparable patterns. SMAD7 levels decreased, consistent with low miR-15b and miR21b, suggesting disrupted inhibition of the TGFβ pathway, especially in aggressive types.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mirnas-in-signal-transduction-of-smad-proteins-in-breast-cancer/340153/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mirnas-in-signal-transduction-of-smad-proteins-in-breast-cancer/340153.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which breast cancer subtypes were included in the study?","Question",{"text":112,"@type":113},"The study included luminal A, luminal B (HER2− and HER2+), non-luminal HER2+, and TNBC. Each subtype had a specified patient count.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were gene and protein activities related to SMAD signaling measured?",{"text":117,"@type":113},"Gene expression related to SMAD signaling was determined using mRNA microarrays and RT-qPCR, while protein expression was assessed using ELISA.",{"name":119,"@type":110,"acceptedAnswer":120},"What main miRNA-SMAD expression patterns were reported?",{"text":121,"@type":113},"SMAD3 and SMAD5 were overexpressed across all subtypes, associated with reduced miR-145; SMAD4 and miR-155 showed similar findings. SMAD7 was reduced, potentially due to low miR-15b and miR21b.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340153,1790472536,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Article  \nmiRNAs in Signal Transduction of SMAD Proteins in Breast Cancer  \nTomasz Sirek 1,2,*, Agata Sirek 1,2, Przemysław Borawski 3, Nikola Zmarzły 2, Joanna Sułkowska 2, Katarzyna Król-Jatr˛ega 1,2, Marcin Opławski 4,5, Dariusz Boro ´n 2,4,6,7, Michał Chalcarz 2,8,9, Piotr Ossowski 2, Konrad Dziobek 2, Damian Strojny 2,10,11, Kacper Boro ´n 2, Dominika Janiszewska-Bil 2  \nand Beniamin Oskar Grabarek 2,12  \nCitation: Sirek, T.; Sirek, A.; Borawski, P.; Zmarzły, N.; Sułkowska, J.;  \nKról-Jatr˛ega, K.; Opławski, M.; Boro ´n, D.; Chalcarz, M.; Ossowski, P.; et al. miRNAs in Signal Transduction of SMAD Proteins in Breast Cancer. Int.  \nJ. Mol. Sci. 2024, 25, 10088. [https://](https://)[ ](https://)[doi.org/10.3390/ijms251810088](doi.org/10.3390/ijms251810088)  \nAcademic Editor: Jennifer Sims-Mourtada  \nReceived: 16 August 2024  \nRevised: 10 September 2024  \nAccepted: 18 September 2024  \nPublished: 19 September 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Plastic and Reconstructive Surgery, Hospital for Minimally Invasive and Reconstructive Surgery in Bielsko-Biała, 43-316 Bielsko-Biala, Poland; [agatasirek85@gmail.com](agatasirek85@gmail.com) (A.S.); [katarzynakroljatrenga@gmail.com](katarzynakroljatrenga@gmail.com) (K.K.-J.)  \n2 Department of Medical and Health Sciences, Collegium Medicum, WSB University, 41-300 Dabrowa Górnicza, Poland; [nikola.zmarzly@gmail.com](nikola.zmarzly@gmail.com) (N.Z.); [joanna.sulkowska@wsb.edu.pl](joanna.sulkowska@wsb.edu.pl) (J.S.); [dariusz.boron@gmail.com](dariusz.boron@gmail.com) (D.B.); [chalcarzmichal@gmail.com](chalcarzmichal@gmail.com) (M.C.); [drpiotrossowski@gmail.com](drpiotrossowski@gmail.com) (P.O.); [konraddziobek28@gmail.com](konraddziobek28@gmail.com) (K.D.); [strojny.ds@gmail.com](strojny.ds@gmail.com) (D.S.); [q375@icloud.com](q375@icloud.com) (K.B.); [dominika.bjaniszewska@gmail.com](dominika.bjaniszewska@gmail.com) (D.J.-B.); [bgrabarek7@gmail.com](bgrabarek7@gmail.com) (B.O.G.)  \n3 Independent Researcher, 87-800 Włocławek, Poland; [przembor3@gmail.com](przembor3@gmail.com)  \n4 Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, 31-826 Kraków, Poland; [marcin.oplawski@gmail.com](marcin.oplawski@gmail.com)  \n5 Department of Gynecology and Obstetrics, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University in Cracow, 30-705 Kraków, Poland  \n6 Institute of Clinical Science, Skłodowska-Curie Medical University, 00-136 Warszawa, Poland  \n7 Department of Gynecology and Obstetrics, TOMMED Specjalisci od Zdrowia, 40-662 Katowice, Poland  \n8 Chalcarz Clinic-Aesthetic Surgery, Aesthetic Medicine, 60-001 Poznan, Poland  \n9 Bie ´nkowski Medical Center-Plastic Surgery, 85-020 Bydgoszcz, Poland  \n10 Institute of Health Care, National Academy of Applied Sciences in Przemy´sl, 37-700 Przemy´sl, Poland  \n11 New Medical Techniques Specjalist Hospital of St. Family in Rudna Mała, 36-054 Rudna Mala, Poland  \n12 Department of Molecular, Biology Gyncentrum Fertility Clinic, 40-055 Katowice, Poland  \n* Correspondence: [drtskierka@gmail.com](drtskierka@gmail.com)  \nAbstract: The aim of this study was to identify miRNAs that could potentially influence the activity of SMAD proteins involved in TGFβ signal transduction in five types of breast cancer in Polish women. Patients with five breast cancer subtypes were included in the study: luminal A (n = 130), luminal B HER2 − (n = 100), luminal B HER2+ (n = 96), non-luminal HER2+ (n = 36), and TNBC (n = 43) . During surgery, tumor tissue was removed along with a margin of healthy tissue (control) . Molecular analysis included determination of t","cbCaiquyUP67B3gB","https://ap.wps.com/l/cbCaiquyUP67B3gB","pdf",272786,"English","# Introduction\n## Study overview\n## Molecular and protein analyses\n## miRNA profiling and database usage","[{\"question\":\"Which breast cancer subtypes were included in the study?\",\"answer\":\"The study included luminal A, luminal B (HER2− and HER2+), non-luminal HER2+, and TNBC. Each subtype had a specified patient count.\"},{\"question\":\"How were gene and protein activities related to SMAD signaling measured?\",\"answer\":\"Gene expression related to SMAD signaling was determined using mRNA microarrays and RT-qPCR, while protein expression was assessed using ELISA.\"},{\"question\":\"What main miRNA-SMAD expression patterns were reported?\",\"answer\":\"SMAD3 and SMAD5 were overexpressed across all subtypes, associated with reduced miR-145; SMAD4 and miR-155 showed similar findings. SMAD7 was reduced, potentially due to low miR-15b and miR21b.\"}]","miRNAs in Signal Transduction of SMAD Proteins in Breast Cancer | PDF",1790034518,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d52e35af10a6853ad5c68c7cb35711e.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/156c827bbb8ae550d5b599646ee7e099.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8542751565d46b412f5251fb1e85529d.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6158b6b8bcc80086611c123e71f8f194.webp",980,1385]